Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Invest in 10,000+ US Stocks and ETFs
* Offering through VF Securities, Inc. (member FINRA/SIPC)
Diversify into RBI-regulated P2P lending platforms and earn up to 11.5% p.a.
Invest in curated
corporate, gold, and govt. bonds
Earn income
while helping India move to clean energy
Connect with investors, share insights, and grow together.
Master the world of Alternative Investments with our in-depth courses
Stay up to date on latest investing trends and other announcements
Explore our range of financial tools to streamline your investment planning.
Read about our journey and get to know the leadership team at Vested
Cara Therapeutics, Inc. is a development-stage biopharmaceutical company. The Company is focused on treatment paradigm to improve the lives of patients suffering from chronic pruritus. It is developing an oral formulation of difelikefalin, a selective, predominantly peripherally acting, non-scheduled Kappa opioid receptor agonist, for the treatment of chronic neuropathic pruritus associated with Notalgia Paresthetica (NP), a common, underdiagnosed neuropathy affecting the upper back. It is conducting Phase II/III Clinical Program in NP. The program is comprised of two studies - KOURAGE 1 and KOURAGE 2, which are double-blind, placebo-controlled, eight-week studies with patients allowed to roll-over into open-label 52-week extensions. It has developed an IV formulation of difelikefalin, for the treatment of moderate-to-severe pruritus associated with advanced chronic kidney disease in adults undergoing hemodialysis. The IV formulation is out-licensed worldwide. more
Time Frame | TVRD | S&P500 | |
---|---|---|---|
1-Week Return | 24.14%% | % | -3.18%% |
1-Month Return | 18.81%% | % | -7.32%% |
3-Month Return | 32.24%% | % | -11.21%% |
6-Month Return | 91.29%% | % | -9.71%% |
1-Year Return | -28.5%% | % | 4.42%% |
3-Year Return | -96.18%% | % | 20.03%% |
5-Year Return | -96.4%% | % | 88.37%% |
10-Year Return | -95.74%% | % | 150.6%% |
These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.
TVRD | |
---|---|
ROA (LTM) | 0.00% |
ROE (LTM) | 0.00% |
These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.
TVRD | |
---|---|
Trailing PE | NM |
Forward PE | NM |
P/S (TTM) | 0.00 |
P/B | 0.00 |
EV/R | 0.00 |
EV/Ebitda | NM |
TVARDI THERAPEUTICS INC (TVRD) share price today is $17.697
Yes, Indians can buy shares of TVARDI THERAPEUTICS INC (TVRD) on Vested. To buy TVARDI THERAPEUTICS INC from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in TVRD stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.
Yes, you can purchase fractional shares of TVARDI THERAPEUTICS INC (TVRD) via the Vested app. You can start investing in TVARDI THERAPEUTICS INC (TVRD) with a minimum investment of $1.
You can invest in shares of TVARDI THERAPEUTICS INC (TVRD) via Vested in three simple steps:
The price-to-book (P/B) ratio of TVARDI THERAPEUTICS INC (TVRD) is 0.00
The stock symbol (or ticker) of TVARDI THERAPEUTICS INC is TVRD